Tart cherry juice shows a small but measurable effect on blood sugar in clinical research, though the reduction is modest. A meta-analysis of 10 randomized controlled trials found that tart cherry juice consumption lowered fasting blood sugar by an average of just 0.51 mg/dL. That’s statistically significant but barely moves the needle on its own. The real picture is more nuanced, and the effect likely depends on your metabolic health going in.
What the Clinical Trials Actually Show
The evidence for tart cherry juice and blood sugar is mixed, and the details matter. In people who already have metabolic problems, the results look more promising. A randomized, placebo-controlled crossover trial gave Montmorency tart cherry juice to 12 participants with metabolic syndrome for seven days. Fasting glucose dropped significantly compared to placebo, along with improvements in total cholesterol, LDL cholesterol, and blood pressure. These were people whose metabolic systems were already struggling, and the cherry juice appeared to help on multiple fronts simultaneously.
A separate pilot study tracking cherry consumption over 42 days found significant reductions in HbA1c, a marker that reflects average blood sugar over roughly three months. HbA1c improved at every measurement point during the study and remained lower even two weeks after participants stopped eating cherries.
But in healthy adults, the story flips. A 30-day trial gave healthy participants two 8-ounce servings of tart cherry juice daily (each made from 1 fluid ounce of concentrate diluted with water). Glucose levels actually rose over the study period, climbing from baseline through day 14 and day 30. Insulin and glycated albumin didn’t change. The juice’s natural sugar content likely drove blood sugar up in people whose glucose regulation was already working fine.
Why It Helps Some People More Than Others
The key to understanding these contradictory results lies in inflammation. Chronic low-grade inflammation is one of the main drivers of insulin resistance. When inflammatory signaling molecules build up in the body, they interfere with insulin’s ability to do its job, essentially blocking the pathway that tells cells to absorb sugar from the blood. This is a central feature of metabolic syndrome and type 2 diabetes.
Tart cherries are dense with plant compounds that counteract this process. Their anthocyanins (the pigments that give cherries their deep red color) suppress a major inflammatory pathway called NF-κB, reducing the production of inflammatory molecules that cause insulin resistance. Another compound found in tart cherries, chlorogenic acid, activates a cellular energy-sensing pathway called AMPK, which directly improves insulin sensitivity and helps regulate both glucose and fat metabolism. The juice also contains vitamin C and beta-carotene, which neutralize the reactive oxygen species that fuel metabolic dysfunction.
If your body is already dealing with significant inflammation and insulin resistance, these compounds have something to work against. If your metabolism is healthy, adding a sugary juice to your diet simply adds sugar, and the anti-inflammatory benefits don’t have much to offset.
The Sugar Content Trade-Off
Tart cherry juice is not a low-sugar drink. One fluid ounce of concentrate contains about 22 grams of natural sugar, roughly 6 teaspoons. When diluted to make a standard 8-ounce serving per manufacturer instructions, each glass contains around 18 grams of carbohydrate and 77 calories. Two servings a day, the dose used in most studies, means 36 grams of carbohydrate from juice alone.
The saving grace is that tart cherry juice has a glycemic index of 45, which is moderate. For comparison, a typical sports drink sits around 89. That lower GI means tart cherry juice raises blood sugar more gradually than many sweetened beverages, thanks in part to its small amount of fiber and the presence of polyphenols that slow sugar absorption. Still, if you’re monitoring carbohydrate intake closely, two daily servings represent a meaningful addition to your total.
Practical Dosing From the Research
Most studies showing positive metabolic effects used Montmorency tart cherry juice made by diluting 1 fluid ounce of concentrate into 7 fluid ounces of water, consumed twice daily about 8 hours apart. Each serving contained the equivalent of roughly half a pound of tart cherries. Study durations ranged from 7 days to 42 days, with the metabolic syndrome trial showing significant glucose improvements in just one week.
Unsweetened concentrate is important. Many commercial tart cherry juices contain added sugars or are blended with sweeter juices like apple or grape, which would raise the glycemic impact substantially. If you’re trying this for blood sugar purposes, look for 100% tart cherry concentrate with no added sweeteners, and dilute it yourself.
Who Might Benefit
The pattern across studies is fairly consistent: tart cherry juice appears most helpful for people who already have elevated blood sugar, metabolic syndrome, or significant systemic inflammation. For these individuals, the anti-inflammatory and insulin-sensitizing effects of the plant compounds can outweigh the sugar load. The improvements in HbA1c suggest the benefits extend beyond short-term glucose dips into meaningful, longer-term glycemic control.
For people with normal blood sugar and healthy metabolic function, the evidence suggests tart cherry juice is essentially neutral at best, and may temporarily raise glucose levels due to its carbohydrate content. It’s not harmful, but it’s not doing what you might hope. If you fall into this category and are interested in the other documented benefits of tart cherry juice (sleep quality, exercise recovery, blood pressure), the blood sugar impact is likely negligible in either direction.